Literature DB >> 21447907

Preoperative treatment with Botulinum Toxin A before total hip arthroplasty in a patient with tetraspasticity: Case report and review of literature.

S Eibach1, H Krug, E Lobsien, K T Hoffmann, A Kupsch.   

Abstract

We report on a patient with tetraspasticity due to perinatal cerebral palsy requiring total hip joint endoprosthesis because of hip dysplasia. In order to minimize the risk of postoperative luxation Botulinum Toxin A was injected preoperatively into hip flexor and adductor muscles guided by CT-fluoroscopy. Outcome measures included muscle tone, limb position and self-reported pain relief. Seven days post injections the tone of the right hip flexor and adductor muscles improved from three to one points on the five-point Modified Ashworth Scale (MAS), the spastic joint position improved from 45° to 20° in flexion and from 20° to 10° in adduction, and the patient was free of pain. Ten days after injection of Botulinum Toxin operation of total hip joint arthroplasty was performed without complication. Improvement of spasticity sustained for another eight weeks. Subsequent Botulinum Toxin A injection three months post surgery resulted in identical results. This case demonstrates a new preoperative indication for Botulinum Toxin A in patients with an increased muscle tone at the hip who have to undergo total hip joint endoprosthesis to reduce the risk of postoperative luxation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447907     DOI: 10.3233/NRE-2011-0635

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  2 in total

1.  Canadian Physicians' Use of Perioperative Botulinum Toxin Injections to Spastic Limbs: A Cross-sectional National Survey.

Authors:  Farris Kassam; Sepehr Saeidiborojeni; Heather Finlayson; Paul Winston; Rajiv Reebye
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-10-08

2.  AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study.

Authors:  Roberto Eleopra; Sara Rinaldo; Christian Lettieri; Andrea Santamato; Paolo Bortolotti; Carmelo Lentino; Carmine Tamborino; Araldo Causero; Grazia Devigili
Journal:  Toxins (Basel)       Date:  2018-10-31       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.